Search
SOLACI Congress
HomeValvular Aortic valveOther

Other

View Category
Other

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an...
Dr. Omar Tupayachi -
Learn More
Other

TRI-SPA Study: Tricuspid Edge-to-Edge Treatment

Tricuspid regurgitation (TR) is a condition associated with high morbidity and mortality. Currently, surgery is the recommended...
Dr. Carlos Fava -
Learn More
Other

ESC 2024 | TRI.Fr: Transcatheter Tricuspid Repair for the Treatment of Tricuspid Regurgitation

Right-sided heart failure and tricuspid regurgitation (TR) are associated with poor quality of life and an increased...
Dr. Omar Tupayachi -
Learn More
Other

Heterotopic Tricuspid Intervention: TricValve One-Year Outcomes

Severe tricuspid regurgitation (TR) presents a reserved prognosis when not treated in time, seeing as systemic venous...
solaci -
Learn More
Other

Survival in Patients with Tricuspid Regurgitation According to Clinical and Echocardiographic Variables (Clusters)

Survival analysis of patients with tricuspid regurgitation grouped according to comorbidities and echocardiographic variables. For many years, the...
solaci -
Learn More
Other

Prognostic Impact of Acute Kidney Injury Following Tricuspid Transcatheter Edge-to-Edge Repair

Tricuspid failure (TF) mostly affects the elderly and, because of this, is associated with comorbidities that increase...
solaci -
Learn More
Other

TRICVALVE in Patients with Severe Tricuspid Regurgitation: Promising Results at 6 months

Severe tricuspid regurgitation (TR) is associated with high mortality and morbidity. For patients with high surgical risk...
solaci -
Learn More
Antithrombotic Anticoagulants

Antithrombotic Therapy Post Percutaneous Left Atrial Appendage Closure

Percutaneous left atrial appendage closure (LAAO) with Watchman has FDA approval since March 2015, having shown, in...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Is Transcarotid Access a Safe Option in TAVI?

Dr. Carlos Fava - 0
Transcatheter aortic valve implantation (TAVI) should preferably be conducted via transfemoral access, according to European guideline (in patients ≥75 years) and American guideline (in patients...

Fasting versus No Fasting Before Percutaneous Cardiovascular Procedures

Dr. Juan Manuel Pérez - 0
While the American Society of Anesthesiologists guidelines were updated in 2017 to allow for the intake of clear liquids up to two hours and...

Smoking and Its Impact on Cardiovascular Disease 10 Years After Coronary Angioplasty

Dr. Andrés Rodríguez - 0
Smoking is a well-established risk factor for atherosclerotic cardiovascular diseases. However, some historical reports have suggested a lower risk of adverse cardiovascular events in...

Institutional News

See the best images from the Uruguay 2025 Sessions

solaci - 0
Enjoy the best moments of the Uruguay 2025 Conference, held at the Radisson Hotel in Montevideo (Uruguay) on May 7, 8, and 9, 2025. <!--...

How to apply for the SOLACI Research 2025 Grant? Step-by-step explanation video

solaci - 0
You can now rewatch the virtual event we held on April 9th, where we thoroughly reviewed the steps to apply for the SOLACI Research...

April 9 – How to Apply for the SOLACI Research Grant 2025? Virtual Zoom Event

solaci - 0
The Latin American Society of Interventional Cardiology invites you to a new virtual event hosted by the SOLACI Research Department, aimed at clarifying doubts,...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy